Scientists have discovered that aspirin can enhance the immune system's ability to fight cancer by disrupting platelets and allowing T-cells to target and destroy spreading cancer cells. Clinical trials are ongoing to determine the effectiveness and risks of using aspirin in cancer treatment.
Key Points
Aspirin disrupts platelets to allow T-cells to target cancer cells
May work best in early-stage cancers
Potential for new drugs with fewer side effects in the future
Pros
Enhances immune system response to cancer
Potential to help prevent cancer metastasis
Could lead to new cancer treatment options
Cons
Risks of internal bleeding and strokes
Effectiveness not yet confirmed for all types of cancer
Ongoing clinical trials needed to determine safety and efficacy